These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8934801)

  • 1. Late phase response during nasal challenge: effect of astemizole on leukotriene B4 levels.
    Kumar NS; Schaefer PA; Lark G; Frieri M
    Allergy Asthma Proc; 1996; 17(2):93-9. PubMed ID: 8934801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis.
    Frieri M; Therattil J; Chavarria V; Cosachov J; Kumar NS; Wang SF; Sansone G; Etzel J; Dellevecchia D; Zitt M; Mesarina-Wicki B; Nolop KB
    Ann Allergy Asthma Immunol; 1998 Nov; 81(5):431-7. PubMed ID: 9860036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge].
    Kupczyk M; Bocheńska-Marciniak M; Górski P; Kuna P
    Pneumonol Alergol Pol; 2002; 70(11-12):544-9. PubMed ID: 12884563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for neutrophils in intermittent allergic rhinitis.
    Fransson M; Benson M; Wennergren G; Cardell LO
    Acta Otolaryngol; 2004 Jun; 124(5):616-20. PubMed ID: 15267182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines.
    Bensch GW; Nelson HS; Borish LC
    Ann Allergy Asthma Immunol; 2002 May; 88(5):457-62. PubMed ID: 12027065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-stimulated leukotriene B4 and interleukin-8 levels in patients with asthma and allergic rhinitis-modulation by a lipid pathway inhibitor.
    Frieri M; Therattil JM; Zitt M; Bouboulis D; Wang SF; Lark G; Schaefer PA; Sansone G
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):331-6. PubMed ID: 9809497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
    Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
    Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of terfenadine, loratadine, and astemizole in perennial allergic rhinitis.
    Crawford WW; Klaustermeyer WB; Lee PH; Placik IM
    Otolaryngol Head Neck Surg; 1998 May; 118(5):668-73. PubMed ID: 9591867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM; Mucha SM; Detineo M; Naclerio RM
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo.
    Freeland HS; Pipkorn U; Schleimer RP; Bascom R; Lichtenstein LM; Naclerio RM; Peters SP
    J Allergy Clin Immunol; 1989 Mar; 83(3):634-42. PubMed ID: 2466880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene B4 production by blood neutrophils in allergic rhinitis--effects of cetirizine.
    Cheria-Sammari S; Aloui R; Gormand F; Chabannes B; Gallet H; Grosclaude M; Melac M; Rihoux JP; Perrin-Fayolle M; Lagarde M
    Clin Exp Allergy; 1995 Aug; 25(8):729-36. PubMed ID: 7584684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant interleukin-8 on eosinophils' and neutrophils' migration in vivo and in vitro.
    Bocheńska-Marciniak M; Kupczyk M; Górski P; Kuna P
    Allergy; 2003 Aug; 58(8):795-801. PubMed ID: 12859561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
    Evans DJ; Barnes PJ; Spaethe SM; van Alstyne EL; Mitchell MI; O'Connor BJ
    Thorax; 1996 Dec; 51(12):1178-84. PubMed ID: 8994512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
    Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.